SCHEMBL7885255

SCHEMBL7885255

CCOC(=O)c1nc(COC(C)=O)n(Cc2ccccc2)c1C(=O)OCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.50
AGTR1 P30556 1/20 0.49
AGTR2 P50052 1/20 0.49
TSHR P16473 3/20 0.48
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 3/20 0.47
GAA P10253 2/20 0.47
HPGD P15428 2/20 0.47
HSD17B10 Q99714 2/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAPK1 P28482 1/20 0.46
LMNA P02545 3/20 0.45
MAPT P10636 3/20 0.45
PKM P14618 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
POLB P06746 2/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7886357 0.89 CYP19A1 (0.51) CYP19A1AGTR1AGTR2TSHRALDH1A1
SCHEMBL7878433 0.88 CYP19A1 (0.54) CYP19A1AGTR1AGTR2TSHRALDH1A1
SCHEMBL7878581 0.85 CYP19A1 (0.52) CYP19A1AGTR1AGTR2TSHRALDH1A1
SCHEMBL7878712 0.82 TSHR (0.58) CYP19A1TSHRALDH1A1KDM4EGAA
SCHEMBL7883630 0.80 LMNA (0.46) CYP19A1AGTR1AGTR2TSHRALDH1A1
SCHEMBL8861145 0.78 KMT2A (0.45) CYP19A1TSHRALDH1A1KDM4EGAA
SCHEMBL7878415 0.76 TSHR (0.48) CYP19A1AGTR1AGTR2TSHRALDH1A1
SCHEMBL4895350 0.76 ALDH1A1 (0.54) CYP19A1TSHRALDH1A1KDM4EGAA
SCHEMBL7886361 0.75 MAPK8 (0.48) TSHRALDH1A1GAAL3MBTL1LMNA
SCHEMBL182493 0.75 MAPT (0.62) TSHRALDH1A1KDM4EGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0573218-B1 4-Carboxyimidazoles as angiotensin II antagonists and their thrapeutic use SANKYO CO (JP) 2001-03-07 EP disclosed
US-5646171-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1997-07-08 US disclosed
US-5616599-A HYPOTENSIVE AGENTS FOR CARDIOVASCULAR DISORDER SANKYO COMPANY, LIMITED (JP) 1997-04-01 US disclosed
EP-0573218-A2 4-Carboxyimidazoles as angiotensin II antagonists and their thrapeutic use SANKYO COMPANY LIMITED (JP) 1993-12-08 EP disclosed